In addition, gain-of-function p53 mutations have been shown to mediate resistance to BCL2 inhibition, and heat shock protein 90 (HSP90) inhibition was able to destabilize mutant p53 and sensitize SCLC cell lines to BCL2 inhibition [195]. This evidence concerns the gene BCL2 and small cell lung carcinoma.